Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Westerberg

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Gastroenterology and Hepatology|September 5, 2022
Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO studyMasau Sekiguchi, Marcus Westerberg, Anders Ekbom, et al.
The American Journal of Gastroenterology|August 25, 2025
First-Round Fecal Immunochemical Test Concentration Predicts Colorectal Cancer and Advanced Neoplasia in Second-Round ScreeningMasau Sekiguchi, Marcus Westerberg, Christian Löwbeer, et al.
Journal of Clinical Epidemiology|August 19, 2024
Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trialMarcus Westerberg, Hans Garmo, David Robinson, et al.
Plos One|January 18, 2024
Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register studyMarcus Westerberg, Sandra Irenaeus, Hans Garmo, et al.
JNCI Cancer Spectrum|June 3, 2024
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yieldCarl Bonander, Marcus Westerberg, Gabriella Chauca Strand, et al.
Clinical Epidemiology|December 3, 2025
Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in SwedenMarcus Westerberg, Hans Garmo, Jonas F Ludvigsson, et al.
European Urology Open Science|June 1, 2026
Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical ProstatectomyPietro Scilipoti, Max Callenmark, Hans Garmo, et al.
Journal of Medical Screening|August 21, 2025
Variation in fecal hemoglobin concentrations: Cross-sectional analysis of a screening trial and a screening program in SwedenMasau Sekiguchi, Christian Löwbeer, Robert Steele, et al.
Scandinavian Journal of Gastroenterology|December 12, 2023
The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trialMarcus Westerberg, Lars Holmberg, Anders Ekbom, et al.
Journal of the National Cancer Institute|January 17, 2025
Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based studyPietro Scilipoti, Hans Garmo, Rolf Gedeborg, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Gastroenterology and Hepatology|September 5, 2022
Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO studyMasau Sekiguchi, Marcus Westerberg, Anders Ekbom, et al.
The American Journal of Gastroenterology|August 25, 2025
First-Round Fecal Immunochemical Test Concentration Predicts Colorectal Cancer and Advanced Neoplasia in Second-Round ScreeningMasau Sekiguchi, Marcus Westerberg, Christian Löwbeer, et al.
Journal of Clinical Epidemiology|August 19, 2024
Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trialMarcus Westerberg, Hans Garmo, David Robinson, et al.
Plos One|January 18, 2024
Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register studyMarcus Westerberg, Sandra Irenaeus, Hans Garmo, et al.
JNCI Cancer Spectrum|June 3, 2024
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yieldCarl Bonander, Marcus Westerberg, Gabriella Chauca Strand, et al.
Clinical Epidemiology|December 3, 2025
Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in SwedenMarcus Westerberg, Hans Garmo, Jonas F Ludvigsson, et al.
European Urology Open Science|June 1, 2026
Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical ProstatectomyPietro Scilipoti, Max Callenmark, Hans Garmo, et al.
Journal of Medical Screening|August 21, 2025
Variation in fecal hemoglobin concentrations: Cross-sectional analysis of a screening trial and a screening program in SwedenMasau Sekiguchi, Christian Löwbeer, Robert Steele, et al.
Scandinavian Journal of Gastroenterology|December 12, 2023
The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trialMarcus Westerberg, Lars Holmberg, Anders Ekbom, et al.
Journal of the National Cancer Institute|January 17, 2025
Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based studyPietro Scilipoti, Hans Garmo, Rolf Gedeborg, et al.
Pageof 6